Alloy Therapeutics Stock

www.alloytx.comHealthcareFounded: 2020Funding to Date: $136.24MM

Alloy Therapeutics is a biotech ecosystem company, facilitating affordable, non-exclusive access to the entire drug discovery community from academic scientists, small and medium biotech, to the largest biopharma. The company's platform is a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains.

Register for Details

For more details on financing and valuation for Alloy Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Alloy Therapeutics.

Register Today


Management Team

Errik Anderson
Founder & Chief Executive Officer
Heather Schwoebel
Chief Business Officer & Chief Operating Officer
Piotr Bobrowicz
Chief Scientific Officer
Logan Snyder
General Counsel
Ron Adner
Chief Strategy Officer
Dongxing Zha
Chief Technology Officer, TCR Discovery and Engineering
Rachel Rennard
Chief Technology Officer, Antibodies

Board Members

Jason Camm
Thiel Capital
Jason Coloma
Maze Therapeutics
Fabian Hansen
Presight Capital
Alex Kolicich
Ulrik B. Nielsen
Tidal Therapeutics
Logan Snyder
Ulysses Holdings
Anthony Sun
Zentera Therapeutics
Piotr bobrowwicz
Board Member
Alaa Halawa
Board Member

Other companies like Alloy Therapeutics in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


Alloy Therapeutics, a Boston, MA-based biotechnology ecosystem company, raised $42M in Series D funding